Immuron (IMRN) Retained Earnings (2016 - 2025)
Immuron (IMRN) recorded quarterly Retained Earnings of -$824804.3 in Q3 2025, up 98.44% quarter-over-quarter from -$52.8 million in Q2 2025, and down 4.45% on a YoY basis from -$863193.9 in Q3 2024.
Immuron (IMRN) Retained Earnings (2016 - 2025) Analysis & Trends
Immuron's Retained Earnings history runs 10 years deep, the most recent figure standing at -$824804.3 for Q3 2025.
- In Q3 2025, Retained Earnings fell 4.45% year-over-year to -$824804.3; the TTM figure through Sep 2025 stood at -$824804.3 (down 4.45% YoY), while the FY2025 annual figure was -$824804.3, down 4.45% from the prior year.
- Retained Earnings was -$824804.3 for Q3 2025 at Immuron, up from -$52.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $422.6 billion in Q4 2024 to a low of -$52.8 million in Q2 2025.
- Historically, Retained Earnings has averaged $30.2 billion across 5 years, with a median of -$47.4 million in 2023.
- The sharpest annual moves came in 2021 and 2024: Retained Earnings slumped 7526.2% in 2021, then jumped 87575294.61% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$48.3 million in 2021, then climbed by 6.85% to -$45.0 million in 2022, then soared by 98.93% to -$482570.0 in 2023, then surged by 87575294.61% to $422.6 billion in 2024, then slumped by 100.0% to -$824804.3 in 2025.
- The last three Retained Earnings figures came in at -$824804.3 (Q3 2025), -$52.8 million (Q2 2025), and $422.6 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | -824,804.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | -824,804.27 |
| Jun 30, 2025 | -52.80 Mn |
| Dec 31, 2024 | 422.61 Bn |
| Sep 9, 2024 | -789,683.96 |
| Jun 30, 2024 | -52.04 Mn |
| Dec 31, 2023 | -482,569.99 |
| Sep 28, 2023 | -47.23 Mn |
| Aug 30, 2023 | -720,553.96 |
| Jun 30, 2023 | -48.16 Mn |
| Dec 31, 2022 | -44.96 Mn |
| Aug 31, 2022 | -47.58 Mn |
| Jun 30, 2022 | -49.01 Mn |
| Dec 31, 2021 | -48.26 Mn |
| Jun 30, 2021 | -50.77 Mn |
| Dec 31, 2020 | -632,871.95 |
| Sep 1, 2020 | -57.92 Mn |
| Jun 30, 2020 | -37.96 Mn |
| Dec 31, 2019 | -579,164.23 |
| Jun 30, 2019 | 3.01 Mn |
| Dec 31, 2018 | -52.54 Mn |